Search research articles
Contact Us
Filters
Showing results (1-10 of 25) with videos related to
Page
of 3
Sort By:
Cancer Treatment Reviews
|
April 22, 2000
Malignant thymoma: current status and future directions
P N Lara
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 23, 2011
The hazards of randomized phase II trials
P N Lara, M W Redman
Cancer Investigation
|
March 11, 1999
Treatment options in androgen-independent prostate cancer
P N Lara, F J Meyers
Gynecologic Oncology
|
June 1, 1997
Neovaginal malignant melanoma following surgery and radiation for vulvar squamous cell carcinoma
P N Lara, E Hearn, B Leigh
Chest
|
October 1, 1996
Retreatment of recurrent invasive thymoma with platinum, doxorubicin, and cyclophosphamide
P N Lara, P D Bonomi, L P Faber
Seminars in Oncology
|
July 7, 2001
Integration of new chemotherapeutic agents into chemoradiotherapy for stage III non--small cell lung cancer: focus on docetaxel
D R Gandara, P N Lara, Z Goldberg, et al.
Oncology (Williston Park, N.Y.)
|
August 29, 2000
Gemcitabine/carboplatin combination regimens: importance of dose schedule
D R Gandara, D H Lau, P N Lara, et al.
Critical Reviews in Oncology/Hematology
|
January 14, 2000
Molecular biology of prostate carcinogenesis
P N Lara, H J Kung, P H Gumerlock, et al.
Oncology (Williston Park, N.Y.)
|
April 17, 2001
Gemcitabine in combination with new platinum compounds: an update
D R Gandara, M J Edelman, P N Lara, et al.
Anti-Cancer Drugs
|
May 9, 2001
Neoadjuvant therapy for non-small cell lung cancer
D R Gandara, P N Lara, Z Goldberg, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 25) with videos related to
Sort By:
Page
of 3
Cancer Treatment Reviews
|
April 22, 2000
Malignant thymoma: current status and future directions
P N Lara
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 23, 2011
The hazards of randomized phase II trials
P N Lara, M W Redman
Cancer Investigation
|
March 11, 1999
Treatment options in androgen-independent prostate cancer
P N Lara, F J Meyers
Gynecologic Oncology
|
June 1, 1997
Neovaginal malignant melanoma following surgery and radiation for vulvar squamous cell carcinoma
P N Lara, E Hearn, B Leigh
Chest
|
October 1, 1996
Retreatment of recurrent invasive thymoma with platinum, doxorubicin, and cyclophosphamide
P N Lara, P D Bonomi, L P Faber
Seminars in Oncology
|
July 7, 2001
Integration of new chemotherapeutic agents into chemoradiotherapy for stage III non--small cell lung cancer: focus on docetaxel
D R Gandara, P N Lara, Z Goldberg, et al.
Oncology (Williston Park, N.Y.)
|
August 29, 2000
Gemcitabine/carboplatin combination regimens: importance of dose schedule
D R Gandara, D H Lau, P N Lara, et al.
Critical Reviews in Oncology/Hematology
|
January 14, 2000
Molecular biology of prostate carcinogenesis
P N Lara, H J Kung, P H Gumerlock, et al.
Oncology (Williston Park, N.Y.)
|
April 17, 2001
Gemcitabine in combination with new platinum compounds: an update
D R Gandara, M J Edelman, P N Lara, et al.
Anti-Cancer Drugs
|
May 9, 2001
Neoadjuvant therapy for non-small cell lung cancer
D R Gandara, P N Lara, Z Goldberg, et al.
Page
of 3